Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior

Virology

Volumn 367, Issue 1, 2007, Pages 168-174

  Chen, W ^a   Li, F ^a   Mead, L ^a   White, H ^a   Walker, J ^a   Ingram, D A ^a   Roman, A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Human papillomavirus; Keratinocytes

Indexed keywords

ANGIOGENIC FACTOR; PROTEIN HPV16 E6E7; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS;

ANIMALS; CELLS, CULTURED; CERVIX UTERI; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS;

EID: 34548681867     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.05.030     Document Type: Article

References (32)

1. Arbeit J.M., Olson D.C., and Hanahan D. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene 13 (1996) 1847-1857
2. Bequet-Romero M., and Lopez-Ocejo O. Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem. Biophys. Res. Commun. 277 (2000) 55-61
3. Berger K.L., Barriga F., Lace M.J., Turek L.P., Zamba G.J., Domann F.E., Lee J.H., and Klingelhutz A.J. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras. Virology 356 (2006) 68-78
4. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
5. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
6. Bouck N., Stellmach V., and Hsu S.C. How tumors become angiogenic. Adv. Cancer Res. 69 (1996) 135-174
7. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., and Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22 (2003) 5938-5945
8. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., and Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13 (1999) 1382-1397
9. DeFilippis R.A., Goodwin E.C., Wu L., and DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77 (2003) 1551-1563
10. Dobbs S.P., Hewett P.W., Johnson I.R., Carmichael J., and Murray J.C. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br. J. Cancer 76 (1997) 1410-1415
11. Guidi A.J., Abu-Jawdeh G., Berse B., Jackman R.W., Tognazzi K., Dvorak H.F., and Brown L.F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst. 87 (1995) 1237-1245
12. Hall A.H., and Alexander K.A. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J. Virol. 77 (2003) 6066-6069
13. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
14. Herrero R., Castellsague X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., Fernandez L., Idris A., Sanchez M.J., Nieto A., Talamini R., Tavani A., Bosch F.X., Reidel U., Snijders P.J., Meijer C.J., Viscidi R., Munoz N., and Franceschi S. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 95 (2003) 1772-1783
15. Huang S.M., and McCance D.J. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J. Virol. 76 (2002) 8710-8721
16. Jiang M., and Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21 (2002) 6041-6048
17. Kodama J., Seki N., Tokumo K., Hongo A., Miyagi Y., Yoshinouchi M., Okuda H., and Kudo T. Vascular endothelial growth factor is implicated in early invasion in cervical cancer. Eur. J. Cancer 35 (1999) 485-489
18. Lingen M.W., Polverini P.J., and Bouck N.P. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am. J. Pathol. 149 (1996) 247-258
19. Mueller M.M., and Fusenig N.E. Friends or foes-Bipolar effects of the tumour stroma in cancer. Nat. Rev., Cancer 4 (2004) 839-849
20. Munchhof A.M., Li F., White H.A., Mead L.E., Krier T.R., Fenoglio A., Li X., Yuan J., Yang F.C., and Ingram D.A. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Hum. Mol. Genet. 15 (2006) 1858-1869
21. Munoz N., Bosch F.X., de S.S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., and Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
22. Nees M., Geoghegan J.M., Hyman T., Frank S., Miller L., and Woodworth C.D. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75 (2001) 4283-4296
23. Orimo A., Gupta P.B., Sgroi D.C., renzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., and Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 (2005) 335-348
24. Seo K.H., Lee H.S., Jung B., Ko H.M., Choi J.H., Park S.J., Choi I.H., Lee H.K., and Im S.Y. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res. 64 (2004) 6482-6488
25. Smith E.M., Hoffman H.T., Summersgill K.S., Kirchner H.L., Turek L.P., and Haugen T.H. Human papillomavirus and risk of oral cancer. Laryngoscope 108 (1998) 1098-1103
26. Smith-McCune K., Zhu Y.H., Hanahan D., and Arbeit J. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57 (1997) 1294-1300
27. Sprague D.L., Phillips S.L., Mitchell C.J., Berger K.L., Lace M., Turek L.P., and Klingelhutz A.J. Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology 301 (2002) 247-254
28. Toussaint-Smith E., Donner D.B., and Roman A. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 23 (2004) 2988-2995
29. Walker J.E. Angiogenic protocols. In: Methods in Molecular Medicine (2001), Humana Press, Totowa, NJ
30. Wu Y.J., Parker L.M., Binder N.E., Beckett M.A., Sinard J.H., Griffiths C.T., and Rheinwald J.G. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31 (1982) 693-703
31. Zhu Y., Ghosh P., Charnay P., Burns D.K., and Parada L.F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296 (2002) 920-922
32. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92 (2000) 690-698